Vapotherm ROE 2018-2019 | VAPO

Current and historical return on equity (ROE) values for Vapotherm (VAPO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Vapotherm ROE for the three months ending September 30, 2019 was -107.95%.
Vapotherm ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-09-30 $-0.05B $0.07B -111.23%
2019-06-30 $-0.05B $0.03B -160.66%
2019-03-31 $-0.05B $0.04B -202.15%
2018-12-31 $-0.04B $0.05B -330.77%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.219B $0.042B
Vapotherm Inc. is a medical technology company. It designs and develops respiratory devices for the treatment of chronic lung and acute breathing disorders. The Company provides flow vapor transfer cartridges, delivery tubes and disinfection kits. Vapotherm Inc. is based in Exeter, New Hampshire.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $158.560B 27.67
Medtronic (MDT) Ireland $157.266B 21.73
Stryker (SYK) United States $82.983B 26.82
Boston Scientific (BSX) United States $58.973B 26.61
Baxter (BAX) United States $47.553B 28.84
EssilorLuxottica Societe Anonyme (ESLOY) France $33.044B 0.00
Zimmer Biomet Holdings (ZBH) United States $32.992B 20.38
Lonza Group Ag (LZAGY) Switzerland $31.551B 0.00
Coloplast (CLPBY) Denmark $29.743B 45.90
Terumo (TRUMY) Japan $27.160B 33.90
ResMed (RMD) United States $25.539B 44.37
Smith & Nephew SNATS (SNN) United Kingdom $20.941B 0.00
Sunny Optical Technology (SNPTF) China $18.537B 0.00
Insulet (PODD) United States $13.126B 624.47
Bio-Rad Laboratories (BIO) United States $12.082B 56.45
William Demant Holdings (WILYY) Denmark $7.896B 0.00
Perrigo (PRGO) Ireland $7.855B 14.65
Canopy Growth (CGC) Canada $7.731B 0.00
GN STORE NORD (GNNDY) Denmark $7.537B 38.94
Hill-Rom Holdings (HRC) United States $7.334B 21.09
DiaSorin S.p.A (DSRLF) Italy $7.161B 0.00
Haemonetics (HAE) United States $6.077B 37.41
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
Envista Holdings (NVST) United States $4.648B 0.00
ICU Medical (ICUI) United States $4.424B 28.84
NuVasive (NUVA) United States $4.127B 32.50
GW Pharmaceuticals (GWPH) United Kingdom $3.926B 0.00
Neogen (NEOG) United States $3.835B 63.83
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.773B 0.00
Quidel (QDEL) United States $3.367B 29.56
Agios Pharmaceuticals (AGIO) United States $3.033B 0.00
National Vision Holdings (EYE) United States $2.670B 60.27
Aurora Cannabis (ACB) Canada $1.847B 0.00
AtriCure (ATRC) United States $1.734B 0.00
TG Therapeutics (TGTX) United States $1.571B 0.00
Cardiovascular Systems (CSII) United States $1.560B 0.00
InMode (INMD) Israel $1.406B 0.00
NanoString Technologies (NSTG) United States $1.204B 0.00
Aphria (APHA) $1.151B 0.00
Phibro Animal Health (PAHC) United States $1.095B 21.65
VAREX IMAGING (VREX) United States $0.997B 20.71
PetIQ (PETQ) United States $0.956B 23.32
Quanterix (QTRX) United States $0.790B 0.00
Cerus (CERS) United States $0.779B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.721B 27.60
Lantheus Holdings (LNTH) United States $0.653B 16.31
Omeros (OMER) United States $0.653B 0.00
LeMaitre Vascular (LMAT) United States $0.602B 34.22
Surmodics (SRDX) United States $0.535B 61.52
MacroGenics (MGNX) United States $0.497B 0.00
Organigram Holdings (OGI) Canada $0.444B 0.00
HEXO (HEXO) $0.432B 0.00
OraSure Technologies (OSUR) United States $0.422B 25.33
Owens & Minor (OMI) United States $0.420B 15.56
Utah Medical Products (UTMD) United States $0.348B 24.71
Meridian Bioscience (VIVO) United States $0.338B 13.62
Zynex (ZYXI) United States $0.333B 37.63
BioLife Solutions (BLFS) United States $0.313B 127.42
Female Health (VERU) United States $0.275B 0.00
Bovie Medical (APYX) United States $0.268B 0.00
Repro-Med Systems (KRMD) United States $0.238B 0.00
Viemed Healthcare (VMD) United States $0.213B 22.48
United Health Products (UEEC) United States $0.188B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.178B 0.00
Liberty Health Sciences (LHSIF) Canada $0.171B 0.00
Cytosorbents (CTSO) United States $0.171B 0.00
Rockwell Medical (RMTI) United States $0.162B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.136B 0.00
Fonar (FONR) United States $0.131B 9.52
Chimerix (CMRX) United States $0.103B 0.00
Surface Oncology (SURF) United States $0.092B 0.00
MRI Interventions (CLPT) United States $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.086B 0.00
United-Guardian (UG) United States $0.079B 20.02
MTech Acquisition (KERN) United States $0.078B 0.00
Nephros (NEPH) United States $0.071B 0.00
Chembio Diagnostics (CEMI) United States $0.070B 0.00
FSD PHARMA INC (HUGE) Canada $0.044B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
NF Energy Saving (BIMI) China $0.033B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.021B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.015B 0.00
Senestech (SNES) United States $0.006B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Valeritas Holdings (VLRX) United States $0.003B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00